UK-based pharmaceutical SME seeks novel early stage molecules in the immuno-oncology space

Summary:

A UK-based pharmaceutical SME s looking for novel small molecules with immune-oncology activity especially in regard to difficult to treat cancers. The SME will further develop these novel compounds to improve their efficacy and safety profiles with a view to licensing the improved molecules to larger pharmaceutical companies to take onto the market. The SME seeks to partner with universities, research Institutes and SMEs in the form of a licensing agreement or technical cooperation agreement.

Reference:

TRUK20161011001

Country:

United Kingdom

Submitted:

December 09 2016

Updated:

December 09 2016

View Partnering Opportunity

KEYWORDS

Market:

In vitro Testing, Trials, Molecular design, Pharmaceuticals/fine chemicals

Technology:

Cytology, Cancerology, Oncology, Medical Research, Pharmaceutical Products / Drugs

NACE:

Manufacture of pharmaceutical preparations, Research and experimental development on biotechnology, Other research and experimental development on natural sciences and engineering